Abstract:Background Lewy body disorders (LBD), encompassing Parkinson disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB), are characterized by alpha-synuclein pathology but often are accompanied by Alzheimer's disease (AD) neuropathological change (ADNC). The medial temporal lobe (MTL) is a primary locus of tau accumulation and associated neurodegeneration in AD. However, it is unclear the extent to which AD copathology in LBD (LBD/AD + ) contributes to MTL-specific patterns of degeneration. We employ a MTL subregional segmentation strategy of T1-weighted (T1w) MRI in biomarker-supported or autopsy-confirmed LBD and LBD/AD + to investigate the anatomic consequences of co-occurring LBD/AD + pathology on neurodegeneration. Methods We studied 167 individuals with clinical diagnoses of LBD (PD, n = 124 (74.3 %); PDD, n = 11 (6.6 %); DLB, n = 32 (19.2 %)) with available T1w MRI and AD biomarkers or autopsy evidence of ADNC. Individuals were further biologically classified as LBD/AD + based on hierarchical evidence of ADNC pathology: 1) AD "intermediate" or "high" by ABC neuropathologic criteria (n = 39 (23.4 %)); 2) positive amyloid PET (n = 2 (1.2 %)); or 3) CSF β-amyloid 1-42 < 185.7 pg/mL n = 126 (75.4 %)). The T1 Automated Segmentation of Hippocampal Subfields (ASHS) pipeline was used to compute volume and thickness measurements of MTL subregions in LBD/AD- and LBD/AD + . Linear regression tested the association of AD copathology and subregion volume/thickness, covarying for age and sex, and intracranial volume for volume measurements. Secondary analyses correlated MTL subregional volume/thickness with cognition and neuropathology. Results LBD/AD + had decreased volume/thickness compared to LBD/AD- in all MTL subregions except posterior hippocampus. The greatest effect sizes were seen in Brodmann Area 35 (BA35) (Cohen's d = 0.62, p = 0.002, β = 0.107 ± 0.034), and entorhinal cortex (ERC) (Cohen's d = 0.56, p = 0.006, β = 0.088 ± 0.031). Smaller differences were seen in the parahippocampal cortex (PHC) (Cohen's d = 0.5, p = 0.012, β = 0.082 ± 0.033), BA36 (Cohen's d = 0.47, p = 0.021, β = 0.090 ± 0.039) and anterior hippocampus (Cohen's d = 0.45, p = 0.029, β = 111.790 ± 50.595). Verbal memory scores positively correlated with volume/thickness in anterior and posterior hippocampus, BA35, ERC and PHC, while visuospatial memory positively correlated only in BA35. In the subset of participants with autopsy, lower ERC volume was associated with a higher tau load in ERC (adjusted odds ratio 0.013, 95 % CI [0.0002, 0.841], uncorrected p = 0.041). Conclusions Relative to LBD/AD-, LBD/AD + has greater T1w MRI evidence of atrophy in multiple MTL subregions. Atrophy in MTL subregions associates with memory performance and tau pathological load. The observed pattern of atrophy largely follows expectation from AD Braak stages, except for posterior hippocampus. Longitudinal studies are needed to validate the hypothesized spread of neurodegeneration.

The Impact of Alzheimer's Disease Susceptibility Loci on Lateral Ventricular Surface Morphology in Older Adults

Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.

A Magnetic Resonance Imaging Study on the Morphological Variation of the Lateral Ventricles in Alzheimer Disease Patients

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Effects of HLA - DRB1 / DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer’s Disease Cohorts

Morphometric Analysis of Hippocampus and Lateral Ventricle Reveals Regional Difference Between Cognitively Stable and Declining Persons

Applying Surface-Based Morphometry to Study Ventricular Abnormalities of Cognitively Unimpaired Subjects Prior to Clinically Significant Memory Decline.

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

Revealing the Correlations Between Brain Cortical Characteristics and Susceptibility Genes for Alzheimer Disease: a Cross-Sectional Study.

Genetic architectures of cerebral ventricles and their overlap with neuropsychiatric traits

Subregional Structural Alterations in Hippocampus and Nucleus Accumbens Correlate with the Clinical Impairment in Patients with Alzheimer’s Disease Clinical Spectrum: Parallel Combining Volume and Vertex-Based Approach

Quantitative Trait Module-Based Genetic Analysis of Alzheimer’s Disease

GWAS-Linked Loci and Neuroimaging Measures in Alzheimer’s Disease

Consistent genes associated with structural changes in clinical Alzheimer's disease spectrum

Association of disease severity with VBM measured reduced regional gray matter volumes in Alzheimer's disease patients

Posterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study

Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment

Genome-wide association study of 23,500 individuals identifies 7 loci associated with brain ventricular volume

Genome-wide Association Study Identifies SIAH3 Locus Influencing the Rate of Ventricular Enlargement in Non-Demented Elders

Morphological and Structural Network Analysis of Sporadic Alzheimer's Disease Brains Based on the APOE4 Gene.

IC–P–025: Regional Network Pattern of MRI Gray Matter Volume in Alzheimer's Dementia